超越多巴胺:精神分裂症治疗的新策略
Paulina Dudzik1, Klaudia Lustyk1, Karolina Pytka1
1Department of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow, Poland.
Medicinal research reviews
|April 23, 2024
概括
针对非多巴胺基通路的新型抗精神病药物候选药物显示出对精神分裂症治疗的前景. 这些药物,包括胆固醇,TAAR1和血清激素调节剂,旨在改善负面和认知症状.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 药物发现 药物发现 药物发现
背景情况:
- 目前的抗精神病药主要向多巴胺基通路,不足以解决精神分裂症的负面和认知症状.
- 对于具有创新作用机制的新型治疗策略有着至关重要的需求.
研究的目的:
- 审查用于治疗精神分裂症的有前途的非多巴胺类药物候选药物.
- 检查新的治疗方法的科学理由和临床试验结果.
主要方法:
- 对新兴抗精神病药物的临床前和临床数据的审查.
- 针对胆固醇,TAAR1和血清系统的化合物的分析.
主要成果:
- 胆固醇M1 / M4受体激活 (例如,KarXT) 显示了潜在的.
- 激活TAAR1受体 (例如,ulotaront) 是一种新的策略.
- 抑制GLYT-1 (例如,伊克莱珀丁) 可能治疗认知缺陷.
- 5-HT2A对抗性 (例如,皮马万塞林,滚皮) 正在调查中.
结论:
- 几种新的非多巴胺类药物正在精神分裂症的临床试验中取得进展.
- 这些候选药物为负面和认知症状提供了潜在的改善,解决了当前治疗方法的局限性.
相关概念视频
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Psychosis and Antipsychotic Drugs: Overview
244
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
244
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
598
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
598
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264


